GLP-1RAs Offer Better Renoprotection in Advanced Diabetic Kidney Disease
Previous GLP-1RA trials have mostly excluded patients with advanced diabetic kidney disease.
Diagnosis & Disease Information
Hyperkalemia Risk Lower With Finerenone vs Spironolactone in CKD
Results are from an indirect comparison of the FIDELITY and AMBER trials.
Avacopan’s Superiority for ANCA-Associated Vasculitis Persists Despite Low eGFR
Investigators conducted a subgroup analysis of patients with eGFR values of 20 mL/min/1.73 m2 or less in the phase 3 ADVOCATE trial.
Talabostat Plus Pembrolizumab Exhibits Activity in mCRPC With SCNC Phenotype
Combination talabostat and pembrolizumab has shown antitumor activity in patients who have metastatic castration-resistant prostate cancer with small-cell neuroendocrine carcinoma phenotype.
Sanofi Follows Lilly, Novo Nordisk in Cutting Insulin Prices
Sanofi is the third company to cut prices on its insulin products and cap out-of-pocket charges to $35 a month
TMP/SMX May Lower Severe Infection Risk in ANCA-Associated Vasculitis
Prophylaxis against Pneumocystis jirovecii pneumonia with trimethoprim-sulfamethoxazole reduced the risk for severe infections by nearly 77%, a study found.
Inaxaplin Reduces Proteinuria in FSGS With APOL1 Variants
Study findings suggest targeted inhibition of APOL1 function can reduce proteinuria.
ACC: Sotatercept Boosts Exercise Capacity With Pulmonary Arterial Hypertension
Significant gains seen in 6-minute walk distance from baseline to week 24
Novo Nordisk to Cut Insulin Prices by Up to 75 Percent
News follows similar move made by Eli Lilly, which said earlier this month that it will cut insulin prices by 70%
Preventing, Managing Hyperuricemia After Kidney Transplantation
Kidney transplant recipients are at high risk for hyperuricemia due to multiple contributing factors.
- Loading...
Loading...
Next post in Hyperuricemia
Loading... 
Loading...